Literature DB >> 21669037

Tissue factor knockdown in porcine islets: an effective approach to suppressing the instant blood-mediated inflammatory reaction.

Xiaoqian Ma1, Bin Ye, Feng Gao, Qi Liang, Qiong Dong, Yin Liu, Pengfei Rong, Wei Wang, Shounan Yi.   

Abstract

Tissue factor (TF) expression on islets has been shown to trigger instant blood-mediated inflammatory reaction (IBMIR), leading to rapid islet loss in portal vein islet transplantation. This study investigated whether antisense RNA-mediated TF gene knockdown in islets could suppress IBMIR as a strategy to overcome IBMIR. Neonatal porcine islet cell clusters (NICCs) were transfected with or without TF-specific antisense RNA or a nonspecific RNA by a lipid-based method. Expression of both TF gene and protein in NICCs was analyzed after transfection by real-time PCR, Western blot, and FACS, respectively. The impact of antisense RNA transfection on NICC viability and in vitro function was examined by FACS and insulin release test, respectively. The effect of TF knockdown in NICCs on IBMIR was assessed with an in vitro tubing loop assay using human blood. A significant reduction in TF gene and protein expression was achieved in TF antisense RNA but not control RNA transfected NICCs, which did not affect NICCs' viability or their insulin secreting capacity. Incubation of TF antisense RNA transfected with human blood resulted in a considerable reduction in blood clot formation, platelet consumption, and complement and coagulation activation compared to that observed in the loops containing human blood and untreated or control RNA transfected NICCs. Consistent with these findings, infiltrating neutrophils in the blood clots with entrapped TF antisense RNA transfected NICCs was also reduced substantially compared to that seen in the clots containing untreated or control RNA transfected NICCs. This study presents a nontoxic TF antisense RNA-mediated TF knockdown in porcine islets that leads to an effective suppression of IBMIR, suggesting a potentially new strategy to improve islet transplantation outcomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669037     DOI: 10.3727/096368911X580563

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  10 in total

Review 1.  Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future.

Authors:  Zhengzhao Liu; Wenbao Hu; Tian He; Yifan Dai; Hidetaka Hara; Rita Bottino; David K C Cooper; Zhiming Cai; Lisha Mou
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

2.  Mesenchymal stem cells alleviate hypoxia-induced oxidative stress and enhance the pro-survival pathways in porcine islets.

Authors:  Yixiong Tan; Wei Nie; Cheng Chen; Xuesong He; Yuzhi Xu; Xiaoqian Ma; Juan Zhang; Mengqun Tan; Pengfei Rong; Wei Wang
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-01

3.  Dual islet transplantation modeling of the instant blood-mediated inflammatory reaction.

Authors:  B M Martin; K P Samy; M C Lowe; P W Thompson; J Cano; A B Farris; M Song; C R Dove; F V Leopardi; E A Strobert; J B Jenkins; B H Collins; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2015-02-19       Impact factor: 8.086

4.  The role of human CD46 in early xenoislet engraftment in a dual transplant model.

Authors:  Kannan P Samy; Qimeng Gao; Robert Patrick Davis; Mingqing Song; Zachary W Fitch; Michael S Mulvihill; Andrea L MacDonald; Frank V Leopardi; Tam How; Kyha D Williams; Gayathri R Devi; Bradley H Collins; Xunrong Luo; Allan D Kirk
Journal:  Xenotransplantation       Date:  2019-06-20       Impact factor: 3.907

Review 5.  The production of multi-transgenic pigs: update and perspectives for xenotransplantation.

Authors:  Heiner Niemann; Bjoern Petersen
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

6.  mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors.

Authors:  C S Lewis; H Elnakat Thomas; M A Orr-Asman; L C Green; R E Boody; K Matiash; A Karve; Y M Hisada; H W Davis; X Qi; C A Mercer; F V Lucas; B J Aronow; N Mackman; H H Versteeg; V Y Bogdanov
Journal:  J Thromb Haemost       Date:  2018-12-25       Impact factor: 16.036

Review 7.  Gene Editing, Gene Therapy, and Cell Xenotransplantation: Cell Transplantation Across Species.

Authors:  Nizar I Mourad; Pierre Gianello
Journal:  Curr Transplant Rep       Date:  2017-07-21

8.  Endothelial microparticles released by activated protein C protect beta cells through EPCR/PAR1 and annexin A1/FPR2 pathways in islets.

Authors:  Guillaume Kreutter; Mohamad Kassem; Ali El Habhab; Philippe Baltzinger; Malak Abbas; Julie Boisrame-Helms; Lamia Amoura; Jean Peluso; Blandine Yver; Zobairi Fatiha; Geneviève Ubeaud-Sequier; Laurence Kessler; Florence Toti
Journal:  J Cell Mol Med       Date:  2017-05-19       Impact factor: 5.310

9.  Islet transplantation into brown adipose tissue can delay immune rejection.

Authors:  Jessica D Kepple; Jessie M Barra; Martin E Young; Chad S Hunter; Hubert M Tse
Journal:  JCI Insight       Date:  2022-02-22

Review 10.  Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges.

Authors:  Anthony Bruni; Boris Gala-Lopez; Andrew R Pepper; Nasser S Abualhassan; Am James Shapiro
Journal:  Diabetes Metab Syndr Obes       Date:  2014-06-23       Impact factor: 3.168

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.